MUSSELMAN GENE 4

Accession 0001181431-10-054537

CIK 0001316631other

View on SEC.gov Company Profile

Filed

Nov 8, 7:00 PM ET

Accepted

Nov 9, 7:53 PM ET

Size

52.1 KB

Accession

0001181431-10-054537

Insider Transaction Report

Form 4

Period: 2010-11-05

Liberty Global, Inc.LBTY

MUSSELMAN GENE

President & COO--UPC Broadband

Transactions

Exercise/Conversion
Stock Appreciation Rights
2010-11-05−44,393→ 0 total
Exercise: $10.90Exp: 2013-10-01→ Series A Common (44,393 underlying)
Exercise/Conversion
Stock Appreciation Rights
2010-11-05−44,393→ 0 total
Exercise: $10.31Exp: 2013-10-01→ Series C Common (44,393 underlying)
Exercise/Conversion
Stock option (right to buy)
2010-11-05−85,000→ 0 total
Exercise: $24.02Exp: 2012-07-14→ Series A Common (85,000 underlying)
Exercise/Conversion
Series C common stock
2010-11-05$10.31/sh+44,393$457,692→ 272,018 total
Exercise/Conversion
Stock option (right to buy)
2010-11-05−46,690→ 0 total
Exercise: $19.64Exp: 2014-11-24→ Series A Common (46,690 underlying)
Sale
Series C common stock
2010-11-05$37.60/sh−24,467$919,959→ 13,925 total
Exercise/Conversion
Series A common stock
2010-11-05$20.48/sh+42,500$870,400→ 188,130 total
Sale
Series A common stock
2010-11-05$39.38/sh−188,130$7,407,807→ 22,019 total
Sale
Series A common stock
2010-11-08$38.80/sh−22,019$854,403→ 0 total
Sale
Series A common stock
2010-11-05$40.00/sh−3,417$136,680→ 13,940 total
Exercise/Conversion
Series A common stock
2010-11-05$27.48/sh+7,434$204,286→ 239,957 total
Exercise/Conversion
Series C common stock
2010-11-05$22.73/sh+85,000$1,932,050→ 141,425 total
Exercise/Conversion
Stock option (right to buy)
2010-11-05−85,000→ 0 total
Exercise: $22.73Exp: 2012-07-14→ Series C Common (85,000 underlying)
Exercise/Conversion
Stock option (right to buy)
2010-11-05−86,200→ 0 total
Exercise: $18.60Exp: 2014-11-24→ Series C Common (86,200 underlying)
Exercise/Conversion
Stock Appreciation Rights
2010-11-05−7,434→ 52,038 total
Exercise: $27.48Exp: 2017-05-01→ Series A Common (7,434 underlying)
Exercise/Conversion
Series A common stock
2010-11-05$19.64/sh+46,690$916,992→ 60,630 total
Exercise/Conversion
Series A common stock
2010-11-05$24.02/sh+85,000$2,041,700→ 145,630 total
Exercise/Conversion
Series A common stock
2010-11-05$10.90/sh+44,393$483,884→ 232,523 total
Tax Payment
Series A common stock
2010-11-05$39.43/sh−29,808$1,175,329→ 210,149 total
Exercise/Conversion
Series C common stock
2010-11-05$27.08/sh+7,434$201,313→ 279,452 total
Exercise/Conversion
Series C common stock
2010-11-05$19.92/sh+42,500$846,600→ 56,425 total
Exercise/Conversion
Series C common stock
2010-11-05$18.60/sh+86,200$1,603,320→ 227,625 total
Tax Payment
Series C common stock
2010-11-05$37.08/sh−30,013$1,112,882→ 249,439 total
Sale
Series C common stock
2010-11-08$36.66/sh−21,814$799,679→ 0 total
Exercise/Conversion
Stock option (right to buy)
2010-11-05−42,500→ 0 total
Exercise: $20.48Exp: 2013-05-02→ Series A Common (42,500 underlying)
Exercise/Conversion
Stock Appreciation Rights
2010-11-05−7,434→ 52,038 total
Exercise: $27.08Exp: 2017-05-01→ Series C Common (7,434 underlying)
Sale
Series C common stock
2010-11-05$37.10/sh−227,625$8,444,660→ 21,814 total
Exercise/Conversion
Stock option (right to buy)
2010-11-05−42,500→ 0 total
Exercise: $19.92Exp: 2013-05-02→ Series C Common (42,500 underlying)

Holdings

Series A common stock
(indirect: By 401(k))
1,873
Series C common stock
(indirect: By 401(k))
5,321

Footnotes (8)

[F1]The price reflects a weighted average of sales made at prices ranging from $37.50 to $37.92. The Reporting Person agrees to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
[F2]The price reflects a weighted average of sales made at prices ranging from $39.31 to $39.75. The Reporting Person agrees to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
[F3]The price reflects a weighted average of sales made at prices ranging from $36.70 to $37.42. The Reporting Person agrees to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
[F4]The price reflects a weighted average of sales made at prices ranging from $38.651 to $39.001. The Reporting Person agrees to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
[F5]The price reflects a weighted average of sales made at prices ranging from $36.551 to $36.762. The Reporting Person agrees to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
[F6]The option is immediately exercisable.
[F7]The SARs vest in four equal annual installments commencing October 1, 2005.
[F8]The SARs provide for vesting of 12.5% of the shares on November 1, 2010, and the remaining shares in 14 equal quarterly installments commencing February 1, 2011.

Documents

1 file

4
rrd290675.xmlPrimary
MUSSELMAN

Issuer

Liberty Global, Inc.

CIK 0001316631

→

Entity typeother

Related Parties

filerCIK 0001116776

Filing Metadata

Form type: 4
Filed: Nov 8, 7:00 PM ET
Accepted: Nov 9, 7:53 PM ET
Size: 52.1 KB

View on SEC.gov